HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $172,000 | +63.8% | 6,541 | +20.7% | 0.00% | – |
| Q4 2018 | $105,000 | +208.8% | 5,420 | +211.5% | 0.00% | – |
| Q3 2018 | $34,000 | -80.5% | 1,740 | -85.9% | 0.00% | -100.0% |
| Q1 2018 | $174,000 | -67.8% | 12,300 | -71.2% | 0.01% | -63.6% |
| Q3 2017 | $541,000 | +79.7% | 42,718 | +68.3% | 0.02% | +69.2% |
| Q2 2017 | $301,000 | -61.8% | 25,377 | -41.5% | 0.01% | -75.5% |
| Q3 2016 | $787,000 | -24.5% | 43,409 | -31.4% | 0.05% | -24.3% |
| Q2 2016 | $1,042,000 | -39.8% | 63,291 | -20.8% | 0.07% | -48.5% |
| Q4 2015 | $1,732,000 | +509.9% | 79,959 | +457.6% | 0.14% | +547.6% |
| Q3 2015 | $284,000 | +305.7% | 14,339 | +605.3% | 0.02% | +250.0% |
| Q2 2015 | $70,000 | +6900.0% | 2,033 | +3966.0% | 0.01% | – |
| Q1 2015 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
| Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
| ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
| JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
| NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
| Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
| TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |